MSA provides market analysis services using de-identified clinical laboratory data to help life sciences companies understand product markets. They offer access to HIPAA-compliant lab test ordering and results data, as well as services including market segmentation, competitive analysis, and marketing planning. MSA's laboratory data insights can help companies better target product development and marketing activities.

1. MSA: World Leader in Marketing Analytics
Use of De-Identified HIPAA-Complaint Clinical Laboratory Data
for Targeted Marketplace Analysis
Enhance your understanding of the marketplace through the use of lab test ordering and results

2. 2Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
Through quantitative and qualitative market assessment and planning, MSA helps
clients build solid foundations for commercial success. MSA RxDx Consulting and
Data Services offers two levels of services:
1. Data: Access to HIPAA-compliant laboratory data tailored for your use
2. Market Analysis: Market Analysis and Customer Segmentation,
Customer Value Proposition, Competitive Position Assessment, Product
Positioning, and Marketing Planning with a quantitative point of view that
offers results that impact strategic plans and sales activities.
For IVD or BioPharma organizations, the MSA team has access to unique
datasets in the clinical laboratory environment where use of a diagnostic assay
may point to the use of your brand in the marketplace.
MSA RxDx Consulting and Data Services

3. 3Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
Source: http://www.burrillreport.com
Not your father’s laboratory…

4. 4Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
MSA RxDx Lab Orders and Results: US Reach
Source: G2 Reports

5. 5Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
Volume of all testing – Lab Types
Source: G2 Reports

6. 6Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
Marketplace Data: Rx or Dx Data?
 MSA has direct access to data generated by clinicians
ordering specific lab tests and the results of those tests.
Prescription (Rx) based data
identifies clinicians prescribing
Laboratory (Dx) based data identifies
clinicians ordering assays
A blend of both data sets can provide new insights into your marketplace
to better target product development and marketing activities.

7. 7Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
Prescription Based Data
 Prescription (Rx) data may represent a surrogate market for
disease treatment/diagnosis but may not represent the ideal
market segment in which your brand is prescribed.
Prescription based data identifies clinicians
prescribing your brand (and competition)

8. 8Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
Diagnostic Assay Based Data
 Diagnostic (Dx) assay data represent specific markets that
utilize laboratory diagnostics to screen, diagnose, monitor
and treat the market segment.
Laboratory based data can help you
understand the ordering patterns and results
for the assay specific to your brand

9. 9Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
Dx Data
 In certain situations, a potential customer for your brand
may not be prescribing your brand (or the competitor) yet
is utilizing laboratory assays to screen, diagnose, monitor
and treat patients with the disease where your brand
may be used.

10. 10Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
RxDx Marketplace Data
 In many market situations, the ideal customer for your brand
is prescribing and utilizing laboratory assays to screen,
diagnose, monitor and treat patients. Dx data can help
prioritize and optimize marketing efforts.

11. 11Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
MSA RxDx Lab Orders and Results: US Reach
Through our Clinical Laboratory Partners, MSA has access to HIPAA
compliant lab ordering and results data to optimize marketing efforts.

12. 12Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
How do I start using Laboratory Data?
Are there one or more lab assays used to:
diagnose, assess risk,
guide preventative care,
select or exclude patients
for therapy, optimize drug
selection or monitor patients
throughout the disease process?
Does your brand team know how
clinicians use these assays, and the
epidemiology of the results?
Select the assay that is ordered for the
medical condition that your brand is used.
Through our partners MSA will acquire
the HIPAA compliant laboratory data that
is specific to your brands’ disease.
MSA will aggregate and can integrate with
other data sets available.
Brand Teams and Sales Management
can now have additional insights into
the patient population and how
clinicians approach the patient!
The reports, interpretations,
analysis and results enable brand
teams to optimize promotional
efforts.
Predictive
Models
& Reports
MSA will perform analysis,
create models and produce
reports that are specific to the
brand and marketplace
requirements

13. 13Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
Analysis, Models and Reports, with Lab Data
Lab Data
(MONTHLY)
Predictive
Models
& Reports
Pharmaceutical
Company
Targeted Marketing

14. 14Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
About MSA
MSA provides business solutions which integrate
information, technology, analytics, and strategic thinking
 Leader in analytical software and information-based systems, with
over 850 employees worldwide
 Over 50 years of continuous growth through R&D and innovations
 Global presence
 Pittsburgh (headquarters)
 New York
 Atlanta
 High Point, NC
 China
 Malaysia
 UK

15. 15Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
Examples of MSA’s RxDx Experience
 Consumer test and control longitudinal behavioral analysis
 Consumer band choice process for OTC product.
 Physician loyalty grouping and tracking.
 Brand share forecasting for new Rx product (using physician trial
and repeat prescription rates).
 Launch analysis for pharmacogenomic Dx assays.
 Brand clustering and segmentation of Rx category.
 ROI evaluation of DTC advertising for Rx products.
 Marketing mix and ROI analysis for OTC products.
 Pharmaceutical Research & Manufacturers Association study on Rx
drug marketing.
 Ordering pattern analysis (targeting) for cardiovascular Dx.

16. 16Copyright © 2012, MANAGEMENT SCIENCE ASSOCIATES, INC.Corporate
Next Steps
Al Rajeckas, PhD
(949) 370-4300
al.rajeckas@biorxdx.com
Contact us today for a personalized assessment of your specific situation
and challenges and see how MSA can help you meet your business goals.
Providing business solutions which integrate information
technology, analytics and strategic thinking